Clinical Trials Browser

Phase 2 × Postoperative Period × 1 year × Clear all

NCT01709292 2025-10-27

Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer

Phase 2 Active not recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms